Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study
Titel:
Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study
Auteur:
Emmanouilides, Christos Sfakiotaki, Georgia Androulakis, Nikolaos Kalbakis, Kostas Christophylakis, Charalambos Kalykaki, Antonia Vamvakas, Lambros Kotsakis, Athanasios Agelaki, Sofia Diamandidou, Eleni Touroutoglou, Nikolaos Chatzidakis, Adam Georgoulias, Vassilis Mavroudis, Dimitris Souglakos, John